Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: A clinico-pathological study of 130 cases

Citation
B. Sander et al., Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: A clinico-pathological study of 130 cases, INT J CANC, 80(5), 1999, pp. 646-651
Citations number
24
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF CANCER
ISSN journal
00207136 → ACNP
Volume
80
Issue
5
Year of publication
1999
Pages
646 - 651
Database
ISI
SICI code
0020-7136(19990301)80:5<646:CMMISC>2.0.ZU;2-C
Abstract
To assess whether there has been a change in histological features and prog nostic factors of primary cutaneous malignant melanoma (CMM) in young indiv iduals in Sweden, an unselected, population-based study was undertaken; 177 cases of primary CMM in persons below 20 years of age were reported to the Swedish National Cancer Registry between 1973 and 1992, In 87% of the case s, original tumor tissue was available for histo-pathological review. The o riginal diagnosis was verified in 88% (n = 126) of these cases. All tumors had histological features similar to adult CMM; 17% had an associated precu rsor lesion. Superficial spreading melanoma (SSM) was the most common sub-t ype, constituting 20/36 cases in the first decade and 59/90 in the second. Corresponding figures for nodular melanoma (NM) were 11/36 and 23/90. Only 5 melanomas in situ were diagnosed. In girls, the mean thickness of SSM dec reased from 1.5 to 0.6 mm (P < 0.001). Overall mortality was 10%, 22% in th e group with CMM diagnosed 0-15 years of age and 8% in individuals 15-19 ye ars. Fatal CMM cases diagnosed below 15 years of age (n = 4) were NM > 1.6 mm thick and in subjects 15-19 years (n = 9) 44% of fatal tumors were NM wi th a mean thickness of 2.2 mm. Breslow index was the single most important prognostic factor. However, when known prognostic factors were adjusted for in a Cox regression analysis, young age remained an independent risk facto r, with a relative death rate of 0.21 for individuals aged 15-19 compared w ith children < 15 years of age. Int. J, Cancer 80:646-651, 1999. (C) 1999 W iley-Liss, Inc.